A phase i randomized therapeutic MVA-B vaccination improves the magnitude and quality of the T cell immune responses in HIV-1-infected subjects on HAART

  1. Gómez, C.E.
  2. Perdiguero, B.
  3. García-Arriaza, J.
  4. Cepeda, V.
  5. Sánchez-Sorzano, C.Ó.
  6. Mothe, B.
  7. Jiménez, J.L.
  8. Muñoz-Fernández, M.Á.
  9. Gatell, J.M.
  10. De Quirós, J.C.L.B.
  11. Brander, C.
  12. García, F.
  13. Esteban, M.E.
Aldizkaria:
PLoS ONE

ISSN: 1932-6203

Argitalpen urtea: 2015

Alea: 10

Zenbakia: 11

Mota: Artikulua

DOI: 10.1371/JOURNAL.PONE.0141456 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus